Literature DB >> 33762787

Sodium Channel Myotonia and a Novel Gly701Asp Mutation in the SCN4A Gene: From an Ophthalmological Symptom to a Familial Disease.

Filipa Sampaio1, Sérgia Soares2, Sara Pereira1, José Alberto Lemos1, Ágata Mota1.   

Abstract

A six-month-old female child came to an ophthalmology consultation because of a convergent strabismus, myotonia of the orbicularis muscles and difficulty walking in cold environments. Further investigation identified a family history of muscular myotonia in the father, grandmother and uncle. The father also presented with ocular myotonia. The child and family members underwent genetic testing, which was negative for CLCN1 mutations but was positive for a novel heterozygotic Gly701Asp mutation in the SCN4A gene, compatible with sodium channel myotonia. The non-dystrophic myotonias are caused by dysfunction of key skeletal muscle ion channels. Before the advent of DNA sequencing, non-dystrophic myotonias were differentiated based on clinical phenotypes. Sodium channel myotonia disorders are classically of dominant inheritance, in which eye closure myotonia is the most frequent manifestation. Over 40 different mutations have been reported in the SCN4A gene. The Gly701Asp mutation in exon 13 identified in this family has not been described before.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Non-dystrophic myotonia; clcn1; ocular myotonia; scn4a

Year:  2020        PMID: 33762787      PMCID: PMC7946034          DOI: 10.1080/01658107.2020.1779316

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  14 in total

Review 1.  Human skeletal muscle sodium channelopathies.

Authors:  S Vicart; D Sternberg; B Fontaine; G Meola
Journal:  Neurol Sci       Date:  2005-10       Impact factor: 3.307

2.  Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.

Authors:  S Veronica Tan; Emma Matthews; Melissa Barber; James A Burge; Sanjeev Rajakulendran; Doreen Fialho; Richa Sud; Andrea Haworth; Martin Koltzenburg; Michael G Hanna
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

3.  Myotonia congenita with strabismus in a large family with a mutation in the SCN4A gene.

Authors:  H Du; S R Grob; L Zhao; J Lee; M El-Sahn; G Hughes; J Luo; K Schaf; Y Duan; J Quach; X Wei; P Shaw; D Granet; K Zhang
Journal:  Eye (Lond)       Date:  2012-06-01       Impact factor: 3.775

4.  A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians.

Authors:  E Rossignol; J Mathieu; I Thiffault; M Tétreault; M-J Dicaire; N Chrestian; N Dupré; J Puymirat; B Brais
Journal:  Neurology       Date:  2007-11-13       Impact factor: 9.910

5.  Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene.

Authors:  Sébastien Gay; Delphine Dupuis; Laurence Faivre; Alice Masurel-Paulet; Marc Labenne; Marina Colombani; Pierre Soichot; Frédéric Huet; Bernard Hainque; Damien Sternberg; Bertrand Fontaine; Jean-Bernard Gouyon; Christel Thauvin-Robinet
Journal:  Am J Med Genet A       Date:  2008-02-01       Impact factor: 2.802

6.  Redefining the clinical phenotypes of non-dystrophic myotonic syndromes.

Authors:  J Trip; G Drost; H B Ginjaar; F H M Nieman; A J van der Kooi; M de Visser; B G M van Engelen; C G Faber
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-11       Impact factor: 10.154

Review 7.  Myotonic syndromes.

Authors:  Ami Mankodi; Charles A Thornton
Journal:  Curr Opin Neurol       Date:  2002-10       Impact factor: 5.710

Review 8.  Population frequencies of inherited neuromuscular diseases--a world survey.

Authors:  A E Emery
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

9.  Extraocular muscle hypertrophy in myotonia congenita.

Authors:  Bradley Wakeman; Deepti Babu; Jack Tarleton; Ian M Macdonald
Journal:  J AAPOS       Date:  2008-03-04       Impact factor: 1.220

10.  What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed.

Authors:  E Matthews; S V Tan; D Fialho; M G Sweeney; R Sud; A Haworth; E Stanley; G Cea; M B Davis; M G Hanna
Journal:  Neurology       Date:  2008-01-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.